A detailed history of Bridger Management, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Bridger Management, LLC holds 362,349 shares of QURE stock, worth $1.79 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
362,349
Previous 362,349 -0.0%
Holding current value
$1.79 Million
Previous $1.88 Million 13.85%
% of portfolio
0.84%
Previous 0.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.82 - $6.93 $1.75 Million - $2.51 Million
362,349 New
362,349 $1.88 Million
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $1.97 Million - $2.9 Million
350,340 Added 2917.31%
362,349 $2.45 Million
Q3 2023

Nov 14, 2023

SELL
$6.71 - $11.83 $664,229 - $1.17 Million
-98,991 Reduced 89.18%
12,009 $80,000
Q2 2023

Aug 14, 2023

BUY
$11.12 - $22.2 $1.23 Million - $2.46 Million
111,000 New
111,000 $1.27 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $230M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.